AU2014255776B2 - Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions - Google Patents

Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions Download PDF

Info

Publication number
AU2014255776B2
AU2014255776B2 AU2014255776A AU2014255776A AU2014255776B2 AU 2014255776 B2 AU2014255776 B2 AU 2014255776B2 AU 2014255776 A AU2014255776 A AU 2014255776A AU 2014255776 A AU2014255776 A AU 2014255776A AU 2014255776 B2 AU2014255776 B2 AU 2014255776B2
Authority
AU
Australia
Prior art keywords
agents
artificial sequence
synthetic peptide
synthesis
prt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014255776A
Other languages
English (en)
Other versions
AU2014255776A1 (en
Inventor
Nuria Alminana Domenech
Cristina Carreno Serraima
Juan Cebrian Puche
Raquel Delgado Gonzalez
Antonio Vicente Ferrer Montiel
Wim Van Den Nest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lubrizol Advanced Materials Inc
Original Assignee
Lubrizol Advanced Materials Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubrizol Advanced Materials Inc filed Critical Lubrizol Advanced Materials Inc
Publication of AU2014255776A1 publication Critical patent/AU2014255776A1/en
Application granted granted Critical
Publication of AU2014255776B2 publication Critical patent/AU2014255776B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2014255776A 2013-04-15 2014-04-15 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions Active AU2014255776B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382138.9A EP2792684A1 (en) 2013-04-15 2013-04-15 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
EP13382138.9 2013-04-15
PCT/EP2014/057672 WO2014170347A1 (en) 2013-04-15 2014-04-15 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AU2014255776A1 AU2014255776A1 (en) 2015-10-22
AU2014255776B2 true AU2014255776B2 (en) 2018-09-06

Family

ID=48227117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014255776A Active AU2014255776B2 (en) 2013-04-15 2014-04-15 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions

Country Status (9)

Country Link
US (1) US9458194B2 (enExample)
EP (2) EP2792684A1 (enExample)
JP (1) JP6525433B2 (enExample)
KR (1) KR102260346B1 (enExample)
CN (1) CN105408345B (enExample)
AU (1) AU2014255776B2 (enExample)
CA (1) CA2908863C (enExample)
ES (1) ES2639464T3 (enExample)
WO (1) WO2014170347A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US10242871B2 (en) * 2014-10-21 2019-03-26 Nissan Chemical Industries, Ltd. Resist underlayer film-forming composition including a compound having an amino group protected with a tert-butoxycarbonyl group
KR102481341B1 (ko) 2014-10-31 2022-12-23 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 피부 표면으로 활성 작용제의 전달을 위한 열가소성 폴리우레탄 필름
US20180116938A1 (en) * 2015-04-06 2018-05-03 Lg Household & Health Care Ltd. Soluble microneedle for delivering proteins or peptides
WO2017079248A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
HK1257429A1 (zh) 2016-02-04 2019-10-18 ALASTIN Skincare, Inc. 用於侵入性和非侵入性程序性护肤的组合物和方法
CN106176274B (zh) * 2016-08-26 2020-04-10 深圳市维琪医药研发有限公司 一种具有抗敏作用的多肽组合物
CN109996532A (zh) * 2016-10-04 2019-07-09 玫琳凯有限公司 用于处理萎缩纹的方法和组合物
BR102017010169A2 (pt) * 2017-05-15 2019-02-26 Remer Consultores Assessoria Empresarial Ltda. composto, intermediário de síntese, uso na preparação de anticonvulsivante, composição farmacêutica anticonvulsivante
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2018101449A1 (ja) * 2016-11-30 2018-06-07 株式会社資生堂 肌特性解析方法
CA3087881A1 (en) 2017-01-17 2018-07-26 Michael David FORREST Therapeutic inhibitors of the reverse mode of atp synthase
FR3065876B1 (fr) 2017-05-05 2020-08-14 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses
US12337000B2 (en) 2017-07-13 2025-06-24 Michael David FORREST Therapeutic modulators of the reverse mode of ATP synthase
KR102757675B1 (ko) 2017-08-03 2025-01-20 앨러스틴 스킨케어, 인크. 피부 이완 및 신체 윤곽의 개선을 위한 조성물 및 방법
CN108004282B (zh) * 2017-12-01 2021-02-05 中国农业科学院麻类研究所 一种制备灵芝子实体发酵物的方法、发酵物及其应用
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
GB2586577B (en) * 2019-06-14 2024-03-27 Gelmetix Ltd Diagnosis and treatment
CN111596069B (zh) * 2020-06-03 2021-08-06 四川大学华西第二医院 Hsp10在pop早期预警、诊断、预后评估中的应用和产品
EP4188311A1 (en) * 2020-07-29 2023-06-07 Karnak Technologies, LLC Improved formulations of lipophilic subtances for cosmetic uses
AU2021358084A1 (en) * 2020-10-08 2023-06-15 ALASTIN Skincare, Inc. Compositions and methods relating to stimulation of hyaluronic acid
US12223536B2 (en) * 2020-10-19 2025-02-11 Lillycover Co., Ltd. Method for providing customized cosmetic product service
EP4281034A1 (en) 2021-01-24 2023-11-29 Forrest, Michael, David Inhibitors of atp synthase - cosmetic and therapeutic uses
CN115670965B (zh) * 2021-05-17 2024-04-19 杭州朝与暮品牌管理有限公司 一种有效抑制IL-8、TNF-α和IL-6的皮肤抗炎组合物
FR3126309B1 (fr) * 2021-08-30 2024-03-08 Oreal COMPOSITION COSMÉTIQUE à BASE DE GLAUCINE, RETINOL ET PEPTIDES POUR COMBATTRE LE VIEILLISSEMENT DE LA PEAU
CN113876641A (zh) * 2021-11-05 2022-01-04 上海新高姿化妆品有限公司 一种具有抗皱紧致功效的化妆品组合物及其应用
CN116120402B (zh) * 2022-11-04 2024-03-15 深圳市维琪科技股份有限公司 一种环肽及其组合物和用途
CN116440019B (zh) * 2023-03-27 2024-12-27 广东馨柯生命科学有限公司 含咖啡豆发酵液醒肤咖Supferm COFE和活力咖的防脱生发出水霜及其制备方法
WO2024229256A1 (en) * 2023-05-03 2024-11-07 Glo Pharma, Inc. Methods and compositions for cosmetic applications
CN117338628B (zh) * 2023-12-05 2024-04-09 杭州湃肽生化科技有限公司 一种紧肤抗皱组合物及其应用
CN119080885B (zh) * 2023-12-26 2025-09-12 杭州湃肽生化科技有限公司 环九肽-1及其制备方法及应用
CN119462983B (zh) * 2024-11-13 2025-09-23 成都大学 一种大枣改性酸性多糖及其制备方法和用途
CN119241661B (zh) * 2024-11-14 2025-08-01 云南贝泰妮生物科技集团股份有限公司 一种具有抗炎作用的环肽化合物及其制备方法和应用
KR102782681B1 (ko) * 2024-12-16 2025-03-19 주식회사 바이오비쥬 트로포엘라스틴 가교 활성을 갖는 생체 적합성 폴리머를 포함하는 기능성 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050188427A1 (en) * 2004-01-23 2005-08-25 Tiansen Li Lysyl oxidase-like 1 (LOXL1) and elastogenesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126788A1 (en) 2002-08-13 2004-07-01 Schiemann William P. Fibulin-5 and uses thereof
WO2008152507A2 (en) 2007-03-16 2008-12-18 Multigene Vascular Systems, Inc. Compositions and methods for treating ophthalmic disorders
EP2740484A1 (en) * 2012-12-05 2014-06-11 Lipotec, S.A. Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050188427A1 (en) * 2004-01-23 2005-08-25 Tiansen Li Lysyl oxidase-like 1 (LOXL1) and elastogenesis

Also Published As

Publication number Publication date
JP2016519105A (ja) 2016-06-30
US9458194B2 (en) 2016-10-04
EP2986626B1 (en) 2017-06-07
CN105408345B (zh) 2020-08-07
CA2908863C (en) 2022-07-12
JP6525433B2 (ja) 2019-06-05
EP2986626A1 (en) 2016-02-24
BR112015025961A2 (pt) 2017-10-17
ES2639464T3 (es) 2017-10-26
KR20150143752A (ko) 2015-12-23
EP2792684A1 (en) 2014-10-22
KR102260346B1 (ko) 2021-06-03
WO2014170347A1 (en) 2014-10-23
AU2014255776A1 (en) 2015-10-22
US20160075738A1 (en) 2016-03-17
CA2908863A1 (en) 2014-10-23
CN105408345A (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
AU2014255776B2 (en) Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
CA2751436C (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
AU2010310108B2 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
AU2012234366B2 (en) Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
AU2012331140A1 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
AU2016366220A1 (en) Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes
CN104968360A (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
JP7526159B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
BR112015025961B1 (pt) Composto, composição cosmética ou farmacêutica, e, uso de um composto
HK1162540B (en) Peptides for use in cosmetic or pharmaceutical treatment of the skin, mucous membranes and/or scalp

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)